BioCorRx to Present at Sequire Biotechnology Conference on February 2nd
Presentation on Thursday, February 2, 2023 at 2:00 PM ET
ANAHEIM, CA, Jan. 27, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — BioCorRx Inc. (OTCQB:BICX) (the “Company”), a developer and provider of innovative treatment programs for substance use and related disorders, announced today that Lourdes Felix, Chief Executive Officer, Chief Financial Officer, and Director of BioCorRx, and Brady Granier, President and Director of BioCorRx, will be presenting virtually at the Sequire Biotechnology Conference.
Related news for (BICX)
- BioCorRx Reports Business Update for the Second Quarter of 2024
- BioCorRx Pharmaceuticals Inc. Awarded New Patent for Novel Compound to Treat Pain, Depression, and Schizophrenia
- BioCorRx Reports Business Update for 2023
- BioCorRx Pharmaceuticals Inc. Awarded NIDA Grant of Approximately $11 million Over Three Years for Research on BICX104, a Naltrexone Implant in Combination with Bupropion for the Treatment of MUD
- BioCorRx Pharmaceuticals Inc. Appoints Neuroscientist Dr. Kate DeVarney to the Board of Directors